Targeting HDACs: A Promising Therapy for Alzheimer's Disease

被引:149
作者
Xu, Ke [2 ]
Dai, Xue-Ling [1 ,3 ]
Huang, Han-Chang [1 ]
Jiang, Zhao-Feng [1 ,4 ]
机构
[1] Beijing Union Univ, Coll Arts & Sci, Beijing 100191, Peoples R China
[2] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China
[3] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100191, Peoples R China
[4] Beijing Union Univ, Beijing Key Lab Bioact Subst & Funct Foods, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
HISTONE DEACETYLASE INHIBITORS; MOUSE MODEL; TAU PHOSPHORYLATION; MEMORY IMPAIRMENT; REGULATES MEMORY; ACETYLATION; REDUCTION; TOXICITY; DEFICITS; SIRT1;
D O I
10.1155/2011/143269
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epigenetic modifications like DNA methylation and histone acetylation play an important role in a wide range of brain disorders. Histone deacetylases (HDACs) regulate the homeostasis of histone acetylation. Histone deacetylase inhibitors, which initially were used as anticancer drugs, are recently suggested to act as neuroprotectors by enhancing synaptic plasticity and learning and memory in a wide range of neurodegenerative and psychiatric disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD). To reveal the physiological roles of HDACs may provide us with a new perspective to understand the mechanism of AD and to develop selective HDAC inhibitors. This paper focuses on the recent research progresses of HDAC proteins and their inhibitors on the roles of the treatment for AD.
引用
收藏
页数:5
相关论文
共 43 条
  • [1] Histone Deacetylases 1 and 2 Form a Developmental Switch That Controls Excitatory Synapse Maturation and Function
    Akhtar, Mohd W.
    Raingo, Jesica
    Nelson, Erika D.
    Montgomery, Rusty L.
    Olson, Eric N.
    Kavalali, Ege T.
    Monteggia, Lisa M.
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (25) : 8288 - 8297
  • [2] Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
    Bali, P
    Pranpat, M
    Bradner, J
    Balasis, M
    Fiskus, W
    Guo, F
    Rocha, K
    Kumaraswamy, S
    Boyapalle, S
    Atadja, P
    Seto, E
    Bhalla, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) : 26729 - 26734
  • [3] Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3β
    Bardai, Farah H.
    D'Mello, Santosh R.
    [J]. JOURNAL OF NEUROSCIENCE, 2011, 31 (05) : 1746 - 1751
  • [4] Genetics of Alzheimer Disease
    Bekris, Lynn M.
    Yu, Chang-En
    Bird, Thomas D.
    Tsuang, Debby W.
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2010, 23 (04) : 213 - 227
  • [5] Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death
    Bolger, TA
    Yao, TP
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (41) : 9544 - 9553
  • [6] Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
    Bruserud, O.
    Stapnes, C.
    Ersvaer, E.
    Gjertsen, B. T.
    Ryningen, A.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2007, 8 (06) : 388 - 400
  • [7] Histone deacetylase inhibitors: gathering pace
    Carey, Nessa
    La Thangue, Nicholas B.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (04) : 369 - 375
  • [8] HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons
    Chen, Sigeng
    Owens, Geoffrey C.
    Makarenkova, Helen
    Edelman, David B.
    [J]. PLOS ONE, 2010, 5 (05):
  • [9] Multiple roles of HDAC inhibition in neurodegenerative conditions
    Chuang, De-Maw
    Leng, Yan
    Marinova, Zoya
    Kim, Hyeon-Ju
    Chiu, Chi-Tso
    [J]. TRENDS IN NEUROSCIENCES, 2009, 32 (11) : 591 - 601
  • [10] Histone deacetylases (HDACs): characterization of the classical HDAC family
    De Ruijter, AJM
    Van Gennip, AH
    Caron, HN
    Kemp, S
    Van Kuilenburg, ABP
    [J]. BIOCHEMICAL JOURNAL, 2003, 370 : 737 - 749